Cargando…
Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke
Interleukin-33 (IL-33), a newly recognized IL-1 family member, is expressed in various tissues and cells, and involved in pathogenesis of many human diseases. For example, IL-33 plays a protective role in cardiovascular diseases. However, the role of IL-33 in acute ischemic stroke (AIS) remains uncl...
Autores principales: | Li, Qian, Lin, Yuanshao, Huang, Wensi, Zhou, Yulei, Chen, Xiaoli, Wang, Brian, Zhang, Wanli, Cai, Zhengyi, Xue, Jie, Zhang, Wenhui, Yu, Tieer, Wang, Hong, He, Jincai, Jin, Kunlin, Shao, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036956/ https://www.ncbi.nlm.nih.gov/pubmed/27699084 http://dx.doi.org/10.14336/AD.2016.0207 |
Ejemplares similares
-
Left atrial size and risk of recurrent ischemic stroke in a Chinese population
por: Xue, Jie, et al.
Publicado: (2017) -
The Prognostic Value of Serum Cytokines in Patients with Acute Ischemic Stroke
por: Li, Xianmei, et al.
Publicado: (2019) -
Serum interleukin‐33 as a novel marker for long‐term prognosis and recurrence in acute ischemic stroke patients
por: Li, Xian‐Mei, et al.
Publicado: (2019) -
Aging Systemic Milieu Impairs Outcome after Ischemic Stroke in Rats
por: Pan, Mengxiong, et al.
Publicado: (2017) -
Serum lipid profiles and post-stroke depression in acute ischemic stroke patients
por: Shen, Huiping, et al.
Publicado: (2019)